chr11-121058365-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001363644.2(TBCEL):āc.733A>Gā(p.Ile245Val) variant causes a missense change. The variant allele was found at a frequency of 0.000115 in 1,611,484 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.00013 ( 0 hom. )
Consequence
TBCEL
NM_001363644.2 missense
NM_001363644.2 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
TBCEL (HGNC:28115): (tubulin folding cofactor E like) Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be located in cytoskeleton. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10900146).
BS2
High AC in GnomAdExome4 at 183 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBCEL | NM_001363644.2 | c.733A>G | p.Ile245Val | missense_variant | 7/9 | ENST00000683345.1 | NP_001350573.1 | |
TBCEL-TECTA | NM_001378761.1 | c.733A>G | p.Ile245Val | missense_variant | 6/30 | NP_001365690.1 | ||
TBCEL | NM_001130047.3 | c.733A>G | p.Ile245Val | missense_variant | 6/8 | NP_001123519.1 | ||
TBCEL | NM_152715.5 | c.733A>G | p.Ile245Val | missense_variant | 6/8 | NP_689928.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBCEL | ENST00000683345.1 | c.733A>G | p.Ile245Val | missense_variant | 7/9 | NM_001363644.2 | ENSP00000507873 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151928Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151928
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000439 AC: 11AN: 250704Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135490
GnomAD3 exomes
AF:
AC:
11
AN:
250704
Hom.:
AF XY:
AC XY:
4
AN XY:
135490
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000125 AC: 183AN: 1459556Hom.: 0 Cov.: 30 AF XY: 0.000105 AC XY: 76AN XY: 726096
GnomAD4 exome
AF:
AC:
183
AN:
1459556
Hom.:
Cov.:
30
AF XY:
AC XY:
76
AN XY:
726096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151928Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74216
GnomAD4 genome
AF:
AC:
3
AN:
151928
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.733A>G (p.I245V) alteration is located in exon 6 (coding exon 5) of the TBCEL gene. This alteration results from a A to G substitution at nucleotide position 733, causing the isoleucine (I) at amino acid position 245 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;D;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;.
REVEL
Benign
Sift
Benign
T;T;T;.
Sift4G
Benign
T;T;T;.
Polyphen
B;B;.;.
Vest4
MVP
MPC
0.63
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at